Laurus Labs Limited LAURUSLABS.NS Stock
Laurus Labs Limited Price Chart
Laurus Labs Limited LAURUSLABS.NS Financial and Trading Overview
| Laurus Labs Limited stock price | 432.4 INR |
| Previous Close | 366.75 INR |
| Open | 368.05 INR |
| Bid | 369.8 INR x 0 |
| Ask | 369.85 INR x 0 |
| Day's Range | 366.75 - 374.95 INR |
| 52 Week Range | 278.85 - 605.5 INR |
| Volume | 2.56M INR |
| Avg. Volume | 2.98M INR |
| Market Cap | 199.06B INR |
| Beta (5Y Monthly) | 1.257152 |
| PE Ratio (TTM) | 25.208048 |
| EPS (TTM) | 3.49 INR |
| Forward Dividend & Yield | 2 (0.55%) |
| Ex-Dividend Date | May 10, 2023 |
| 1y Target Est | 559.67 INR |
LAURUSLABS.NS Valuation Measures
| Enterprise Value | 214.95B INR |
| Trailing P/E | 25.208048 |
| Forward P/E | 15.813007 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.2953699 |
| Price/Book (mrq) | 4.960869 |
| Enterprise Value/Revenue | 3.558 |
| Enterprise Value/EBITDA | 13.5 |
Trading Information
Laurus Labs Limited Stock Price History
| Beta (5Y Monthly) | 1.257152 |
| 52-Week Change | -21.67% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 605.5 INR |
| 52 Week Low | 278.85 INR |
| 50-Day Moving Average | 322.35 INR |
| 200-Day Moving Average | 382.04 INR |
LAURUSLABS.NS Share Statistics
| Avg. Volume (3 month) | 2.98M INR |
| Avg. Daily Volume (10-Days) | 2.46M INR |
| Shares Outstanding | 538.65M |
| Float | 340.98M |
| Short Ratio | N/A |
| % Held by Insiders | 36.04% |
| % Held by Institutions | 24.74% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 2 |
| Trailing Annual Dividend Yield | 0.54% |
| 5 Year Average Dividend Yield | 41.00% |
| Payout Ratio | 0.1366 |
| Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 13.08% |
| Operating Margin (ttm) | 20.99% |
| Gross Margin | 54.07% |
| EBITDA Margin | 26.35% |
Management Effectiveness
| Return on Assets (ttm) | 10.83% |
| Return on Equity (ttm) | 21.42% |
Income Statement
| Revenue (ttm) | 60.41B INR |
| Revenue Per Share (ttm) | 112.31 INR |
| Quarterly Revenue Growth (yoy) | -3.10% |
| Gross Profit (ttm) | 32.72B INR |
| EBITDA | 15.92B INR |
| Net Income Avi to Common (ttm) | 7.9B INR |
| Diluted EPS (ttm) | 14.66 |
| Quarterly Earnings Growth (yoy) | -55.30% |
Balance Sheet
| Total Cash (mrq) | 484.6M INR |
| Total Cash Per Share (mrq) | 0.89 INR |
| Total Debt (mrq) | 20.15B INR |
| Total Debt/Equity (mrq) | 49.77 INR |
| Current Ratio (mrq) | 1.423 |
| Book Value Per Share (mrq) | 74.493 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 9.94B INR |
| Levered Free Cash Flow (ttm) | -4381024768 INR |
Profile of Laurus Labs Limited
| Country | India |
| State | N/A |
| City | Hyderabad |
| Address | Serene Chambers |
| ZIP | 500034 |
| Phone | 91 40 3980 4333 |
| Website | https://www.lauruslabs.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Laurus Labs Limited, together with its subsidiaries, engages in the development, manufacture, and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C therapeutic areas. It also develops and manufactures oral solid formulations for ARVs, anti-diabetic, cardiovascular, PPIs, and central nervous system. In addition, the company provides contract development and manufacturing services for pharmaceutical companies; and manufactures and sells specialty ingredients used in the nutraceutical, dietary supplements, and cosmeceutical products. Further, it develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceutical field. The company was incorporated in 2005 and is based in Hyderabad, India.
Q&A For Laurus Labs Limited Stock
What is a current LAURUSLABS.NS stock price?
Laurus Labs Limited LAURUSLABS.NS stock price today per share is 432.4 INR.
How to purchase Laurus Labs Limited stock?
You can buy LAURUSLABS.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Laurus Labs Limited?
The stock symbol or ticker of Laurus Labs Limited is LAURUSLABS.NS.
Which industry does the Laurus Labs Limited company belong to?
The Laurus Labs Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Laurus Labs Limited have in circulation?
The max supply of Laurus Labs Limited shares is 539.09M.
What is Laurus Labs Limited Price to Earnings Ratio (PE Ratio)?
Laurus Labs Limited PE Ratio is 123.89684000 now.
What was Laurus Labs Limited earnings per share over the trailing 12 months (TTM)?
Laurus Labs Limited EPS is 3.49 INR over the trailing 12 months.
Which sector does the Laurus Labs Limited company belong to?
The Laurus Labs Limited sector is Healthcare.